Showing results (581-590 of 688) with videos related to

Sort By:
Pageof 69
Annals of the Rheumatic Diseases|July 3, 2008
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritisH M Albers, F A S Kurreeman, J J Houwing-Duistermaat, et al.
Arthritis and Rheumatism|August 29, 2013
Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohortsA Krabben, A G Wilson, D P C de Rooy, et al.
Annals of the Rheumatic Diseases|May 30, 2013
A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED studyL Heimans, K V C Wevers-de Boer, K Visser, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis developmentAnouk L Feitsma, Jane Worthington, Annette H M van der Helm-van Mil, et al.
Annals of the Rheumatic Diseases|November 29, 2013
Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED studyK V C Wevers-de Boer, L Heimans, K Visser, et al.
Arthritis and Rheumatism|May 4, 2011
Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?M P M van der Linden, M R Batstra, L E Bakker-Jonges, et al.
Arthritis and Rheumatism|December 1, 2007
Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope allelesK N Verpoort, K Cheung, A Ioan-Facsinay, et al.
American Journal of Human Genetics|March 25, 2014
Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneityBuhm Han, Dorothée Diogo, Steve Eyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 13, 2025
Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus ErythematosusHugo J van Dooren, Mieke van Schaik, Annemarie L Dorjée, et al.
The Journal of Rheumatology|September 18, 2012
Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapyElisabeth J M Zirkzee, Gerda M Steup-Beekman, Roos C van der Mast, et al.
Pageof 69